Diet-Gene Interactions in p53-Deficient Mice: Insulin-like Growth Factor-1 as a Mechanistic Target
Open Access
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Journal of Nutrition
- Vol. 134 (9) , 2482S-2486S
- https://doi.org/10.1093/jn/134.9.2482s
Abstract
Progress in cancer prevention research is being facilitated by the use of animal models displaying specific genetic susceptibilities for cancer, such as mice deficient in one (+/−) or both (−/−) alleles of the p53 tumor suppressor gene. Our lab, which focuses on nutrition (particularly energy balance/obesity) and molecular carcinogenesis, has shown in p53−/− mice that calorie restriction (CR) increases the latency of spontaneous tumor development (mostly lymphomas) ∼75%, decreases serum insulin-like growth factor (IGF)-1 and leptin levels, and induces apoptosis in immature (lymphoma-susceptible) thymocytes. In heterozygous p53-deficient (p53+/−) mice, CR and a one day/wk fast each significantly delay spontaneous tumor development (a mix of lymphomas, sarcomas, and epithelial tumors) and decreases serum IGF-1 and leptin levels, even when begun late in life. We are presently comparing and combining CR and exercise (treadmill and running wheel) to further elucidate the relationships between energy balance, p53, and tumorigenesis in these models. Furthermore, we have capitalized on the susceptibility of p53+/− mice to chronic, low-dose aromatic amine-induced bladder carcinogenesis to develop a model for evaluating bladder cancer prevention approaches. Using this model, we have established that IGF-1 mediates many of the anti-cancer effects of CR. We are currently conducting oligonucleotide microarray studies to further characterize diet-gene interactions underlying the anti-cancer effects of CR and to determine which of the CR-responsive genes are IGF-1 dependent.Keywords
This publication has 54 references indexed in Scilit:
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- GermlineTP53 mutations and Li-Fraumeni syndromeHuman Mutation, 2003
- Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous MiceThe American Journal of Pathology, 2000
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Mechanism of Cancer Preventive Action of DHEAAnnals of the New York Academy of Sciences, 1995
- Induction of the growth inhibitor IGF-binding protein 3 by p53Nature, 1995
- Association of insulin‐like growth‐factor‐I‐induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF‐7 cellsInternational Journal of Cancer, 1993
- Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumorsCell, 1993
- p53 Mutations in Human CancersScience, 1991
- Plasma Levels of Insulin-Like Growth Factor-1 and Binding Protein-3, and Their Association With Bladder Cancer RiskPublished by Wolters Kluwer Health